{
  "id": 19383633,
  "title": "Daily, oral GLP-1 medication reduced episodes of sleep apnea in adults with excess weight",
  "url": "https://urgent.news/2026/11/10/daily-oral-glp-1-medication-reduced-episodes-of-sleep-apnea-in-adults",
  "topic": "science",
  "section": "Science",
  "published": "2026-11-10T19:40:13.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-11-daily-oral-glp-medication-episodes.html"
  },
  "original_language": "en",
  "account": "Adults with moderate-to-severe sleep apnea and excess weight experienced fewer breathing interruptions during sleep and improved overall health after taking the daily oral GLP-1 medication orforglipron for one year, according to new research presented at the American Heart Association's Scientific Sessions 2026 in Chicago. Orforglipron showed significant benefits compared to a placebo in reducing sleep apnea severity, blood oxygen levels, body weight, inflammatory markers, and blood pressure. Participants taking orforglipron also reported better sleep and higher quality of life. The medication was well-tolerated, with common side effects being mild to moderate nausea, diarrhea, and constipation. Orforglipron could potentially serve as a convenient oral option alongside CPAP therapy or for those unable to use it, offering a promising treatment for obstructive sleep apnea in overweight or obese individuals.",
  "summary": "Adults with moderate-to-severe sleep apnea and excess weight had significantly fewer episodes of breathing interruptions while sleeping after taking the daily oral GLP-1 medication orforglipron for one year, compared with adults in the placebo group, according to new, independent, preliminary late-breaking science presented Monday at the American Heart Association's Scientific Sessions 2026 in…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "STAT News",
        "title": "STAT+: Eli Lilly’s GLP-1 pill Foundayo helped alleviate sleep apnea in studies",
        "url": "https://urgent.news/2026/11/09/stat-eli-lillys-glp-1-pill-foundayo-helped-alleviate-sleep-apnea-in",
        "published": "2026-11-09T14:30:00.000Z"
      },
      {
        "outlet": "Scientific American",
        "title": "Eli Lilly shows GLP-1 weight-loss pill Foundayo can dramatically improve sleep apnea",
        "url": "https://urgent.news/2026/11/09/eli-lilly-shows-glp-1-weight-loss-pill-foundayo-can-dramatically",
        "published": "2026-11-09T18:31:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}